Short answer
Orthofix Medical Inc. (OFIX) filed an 8-K current report with the SEC on May 21, 2026 reporting Item 7.01 (Regulation FD Disclosure). CMS reimbursement changes expected to reduce average Medicare payments for bone growth stimulators by approximately 10% from May 18, 2026.
Orthofix Medical Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- CMS reimbursement changes expected to reduce average Medicare payments for bone growth stimulators by approximately 10% from May 18, 2026
- 2026 net sales outlook reset to $838 million–$848 million
- 2026 non-GAAP adjusted EBITDA outlook lowered to $90 million–$93 million
- No positive free cash flow expected for full-year 2026
- Three-year financial targets withdrawn, with further CMS changes posing additional outlook risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Orthofix Medical Inc. 8-K filings
Get the next OFIX 8-K as it lands
Follow OFIX for push alerts, or ask the research agent what this filing means.